期刊文献+

血红素氧合酶-1保护心力衰竭大鼠肠道结构屏障

Heme oxygenase-1 protects intestine structural barrier in heart failure rats
原文传递
导出
摘要 目的研究血红素氧合酶-1(HO-1)对心力衰竭大鼠肠道结构屏障的保护作用及其作用途径。方法通过冠状动脉结扎术造成心肌梗死建立心力衰竭大鼠模型(雄性,Wistar大鼠),分为MI+Copp(钴-原卟啉)组、MI(心肌梗死)模型组、MI+SnMP(锡中卟啉)组,相同数量(n=10)正常大鼠作为对照组(Control),分别腹腔注射Copp溶液、生理盐水、SnMP溶液、生理盐水。8周后在无菌术操作下取材肝、脾、肠系膜淋巴结,并匀浆细菌培养,计算细菌移位率;取小肠做HE染色观察病理。通过实时定量荧光PCR(Real-time PCR)测定小肠血红素氧合酶-1 RNA的表达,比色法测定小肠一氧化碳(CO)水平。结果同MI比较,MI+Copp明显升高小肠血红素氧合酶-1 RNA表达(P<0.01)及CO浓度(P<0.05),减轻小肠病理改变(P<0.05),并减少细菌移位率(P<0.01)、血浆内毒素含量[门静脉(61.790±21.038)pg/ml,下腔静脉(49.310±25.273)pg/ml,P<0.05]。而MI+SnMP对血红素氧合酶-1 RNA表达无明显影响(P>0.05),但明显降低小肠CO浓度(P<0.05),加重小肠病理改变(P<0.01),并升高细菌移位率(P<0.05)、血浆内毒素含量[门静脉(165.016±40.751)pg/ml,下腔静脉(141.249±40.772)pg/ml,P<0.01]。结论血红素氧合酶-1可明显减少心力衰竭大鼠细菌移位率及血浆内毒素含量,该作用可能与CO保护肠道屏障结构有关。 Objective To investigate the protective effect of heme oxygenase-1(HO-1) on intestine structural barrier in heart failure rats. Methods Heart failure rats model was built by myocardial infarction with coronary ligation method. These rats were randomized into 3 experimental groups(10 rats per group): MI, MI+Copp, and MI+SnMP group receiving injection of saline, Cobalt protoporphyrin solution, Tin mesoporphyrin IX dichloride solution respectively,10 normal rats were set Control.8 weeks later, bacterial translocation incidence, endotoxine level in portal vein and inferior vena cava, expression of HO-1(heme oxygenase-1) and CO in intestine were determined. Results Compared with MI, MI+Copp significantly reduced bacterial translocation incidence, endotoxine level with lower degree of morphology change and elevated concentration of HO-1 and CO, and this was abolished by SnMP. Conclusion MI+ Copp can reduce bacterial translocation incidence and portal endotoxine level, which may be benefit to the protection of CO on intestine barrier.
出处 《中华临床医师杂志(电子版)》 CAS 2014年第3期110-113,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 血红素加氧酶-1 小肠 心力衰竭 大鼠 Wistar Heme oxygenase-1 Intestine small Heart failure Rats Wistar
  • 相关文献

参考文献12

  • 1Levy D,Kenchaiah S,Larson MG,et al.Long-term trends in the incidence of and survival with heart failure[J].N Engl J Med,2002,347(18):1397-1402.
  • 2Chen J,Normand SL,Wang Y,et al.National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries,1998-2008[J].JAMA,2011,306(15):1669-1678.
  • 3Fiore G,Brienza N,Cicala P,et al.Superior mesenteric artery blood flow modifications during off-pump coronary surgery[J].Ann Thorac Surg,2006,82(1):62-67.
  • 4Krack A,Sharma R,Figulla HR,et al.The importance of the gastrointestinal system in the pathogenesis of heart failure[J].Eur Heart J,2005,26(22):2368-2374.
  • 5Lundvig DM,Immenschuh S,Wagener FA.Heme oxygenase,inflammation,and fibrosis:the good,the bad,and the ugly?[J].Front Pharmacol,2012,3:81.
  • 6Alcaraz MJ,Fernandez P,Guillen MI.Anti-inflammatory actions of the heme oxygenase-1 pathway[J].Curr Pharm Des,2003,9(30):2541-2551.
  • 7Niebauer J,Volk HD,Kemp M,et al.Endotoxin and immune activation in chronic heart failure:a prospective cohort study[J].Lancet,1999,353(9167):1838-1842.
  • 8Anker SD,Egerer KR,Volk HD,et al.Elevated soluble CD14receptors and altered cytokines in chronic heart failure[J].Am J Cardiol,1997,79(10):1426-1430.
  • 9Sharma R,Bolger AP,Rauchhaus M,et al.Cellular endotoxin desensitization in patients with severe chronic heart failure[J].Eur J Heart Fail,2005,7(5):865-868.
  • 10Genth-Zotz S,von Haehling S,Bolger AP,et al.Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure[J].Am J Cardiol,2002,90(11):1226-1230.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部